To conclude, we here demonstrate that presence of mature tertiary lymphoid structures, as assessed using L1CAM immunohistochemistry, improves prediction accuracy of recurrence and death beyond clinicopathological risk factors and molecular class in high-risk endometrial cancer patients. Here, L1CAM is linked to endometrial cancer.